Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Drugs of Today (Barcelona, Spain : 1998)|May 28, 2019
LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitorsF Sabatel-Pérez, A García-Ropero, C G Santos-Gallego, et al.
Cardiovascular Drugs and Therapy|June 4, 2025
Sotagliflozin: Two Birds with One Stone?Juan Antonio Requena-Ibáñez, Kristine Mørk Kindberg, Carlos G Santos-Gallego, et al.
Cardiovascular Drugs and Therapy|September 17, 2021
Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial ProtectionJuan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, Anderly Rodriguez-Cordero, et al.
Thrombosis and Haemostasis|March 6, 2007
Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patientsM Urooj Zafar, Michael E Farkouh, Julio Osende, et al.
Thrombosis and Haemostasis|January 12, 2010
A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I studyM Urooj Zafar, Borja Ibáñez, Brian G Choi, et al.
Platelets|April 15, 2021
Effects of electret coating technology on coronary stent thrombogenicityM Urooj Zafar, Jose Javier Bravo-Cordero, Sergi Torramade-Moix, et al.
Clinical Cardiology|November 26, 2004
The incremental value of troponin-I testing in patients with intermediate risk unstable anginaEvan Appelbaum, M Urooj Zafar, H C Glick, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 17, 2007
Validation study of a semi-automated program for quantification of atherosclerotic burdenBrian G Choi, Constantin A Novoselsky, Gemma Vilahur, et al.
European Heart Journal|January 26, 2010
Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depressionM Urooj Zafar, Manuel Paz-Yepes, Daichi Shimbo, et al.
The American Heart Hospital Journal|November 7, 2006
Stress testing and troponin in unstable coronary syndromes: the status trial-clinical outcomes and resource useJosé Navarro Estrada, Florencia Rolandi, Sameer Bansilal, et al.
Pageof 4